TFS timeline
Every TFS batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| TFS-{CAT}-1096 | MK-677 (Ibutamoren mesylate) | 09 May 2026 | 2026-Q2 | 3 | 99.14 | 0.41 | 99.31 | +0.17 | |
| TFS-{CAT}-9733 | SS-31 (Elamipretide) | 06 May 2026 | 2026-Q2 | 2 | 99.61 | 0.20 | 99.30 | -0.31 | |
| TFS-{CAT}-9675 | CJC-1295 with DAC | 05 Apr 2026 | 2026-Q3 | 4 | 98.88 | 0.50 | 99.57 | +0.69 | |
| TFS-{CAT}-9709 | Retatrutide | 31 Mar 2026 | 2026-Q2 | 6 | 98.15 | 1.69 | 97.73 | -0.42 | |
| TFS-{CAT}-9814 | BPC-157 | 29 Mar 2026 | 2026-Q2 | 7 | 99.29 | 0.31 | 99.29 | 0.00 | |
| TFS-{CAT}-1681 | Cagrilintide | 18 Mar 2026 | 2026-Q2 | 13 | 99.34 | 1.34 | 99.90 | +0.56 | |
| TFS-{CAT}-1156 | BPC-157 | 26 Feb 2026 | 2026-Q3 | 2 | 99.67 | 0.25 | 99.77 | +0.10 | |
| TFS-{CAT}-1712 | Selank | 11 Feb 2026 | 2026-Q2 | 13 | 99.87 | 0.30 | 99.90 | +0.03 | |
| TFS-{CAT}-1142 | SS-31 (Elamipretide) | 07 Feb 2026 | 2026-Q2 | 3 | 99.75 | 0.35 | 99.85 | +0.10 | |
| TFS-{CAT}-9679 | Tirzepatide | 11 Jan 2026 | 2026-Q1 | 1 | 98.69 | n<2 | 99.00 | +0.31 | |
| TFS-{CAT}-9391 | Semaglutide | 06 Jan 2026 | 2026-Q2 | 2 | 99.16 | 0.01 | 99.14 | -0.02 | |
| TFS-{CAT}-9792 | Epitalon | 22 Dec 2025 | 2026-Q1 | 4 | 99.93 | 0.21 | 99.43 | -0.50 | |
| TFS-{CAT}-9744 | Semaglutide | 17 Dec 2025 | 2026-Q2 | 7 | 98.27 | 0.41 | 98.44 | +0.17 | |
| TFS-{CAT}-9979 | TB-500 | 05 Dec 2025 | 2026-Q1 | 9 | 99.83 | 0.58 | 99.90 | +0.07 | |
| TFS-{CAT}-1353 | Tirzepatide | 20 Nov 2025 | 2026-Q1 | 14 | 98.96 | 1.70 | 98.91 | -0.05 | |
| TFS-{CAT}-9358 | L-Carnosine | 16 Nov 2025 | 2026-Q2 | 1 | 99.93 | n<2 | 99.75 | -0.18 | |
| TFS-{CAT}-1382 | BPC-157 | 07 Nov 2025 | 2026-Q1 | 3 | 98.86 | 0.29 | 99.15 | +0.29 | |
| TFS-{CAT}-9204 | Kisspeptin-10 | 05 Nov 2025 | 2025-Q4 | 9 | 99.10 | 0.89 | 99.34 | +0.24 | |
| TFS-{CAT}-8947 | Semaglutide | 25 May 2025 | 2025-Q3 | 4 | 98.63 | 1.06 | 98.61 | -0.02 | |
| TFS-{CAT}-1157 | BPC-157 | 21 May 2025 | 2025-Q4 | 11 | 99.80 | 0.41 | 99.52 | -0.28 | |
| TFS-{CAT}-9459 | Semaglutide | 20 Apr 2025 | 2025-Q2 | 2 | 98.78 | 0.36 | 98.99 | +0.21 | |
| TFS-{CAT}-9097 | CJC-1295 (no DAC) | 08 Apr 2025 | 2025-Q2 | 10 | 98.94 | 0.69 | 98.57 | -0.37 | |
| TFS-{CAT}-1220 | CJC-1295 with DAC | 02 Apr 2025 | 2025-Q2 | 14 | 98.64 | 1.17 | 98.68 | +0.04 | SHARED BULK |
| TFS-{CAT}-8964 | BPC-157 | 11 Feb 2025 | 2025-Q3 | 8 | 99.68 | 0.55 | 99.90 | +0.22 | |
| TFS-{CAT}-9918 | Tirzepatide | 06 Feb 2025 | 2025-Q2 | 4 | 97.01 | 0.50 | 97.11 | +0.10 | SHARED BULK |
| TFS-{CAT}-8961 | TB-500 | 09 Jan 2025 | 2025-Q2 | 2 | 99.69 | 0.02 | 99.38 | -0.31 | |
| TFS-{CAT}-9723 | Retatrutide | 16 Dec 2024 | 2025-Q1 | 2 | 98.84 | 0.01 | 98.46 | -0.38 | |
| TFS-{CAT}-1495 | Humanin (HNG) | 23 Aug 2024 | 2025-Q1 | 1 | 99.35 | n<2 | 99.51 | +0.16 | |
| TFS-{CAT}-9795 | CJC-1295 with DAC | 08 Aug 2024 | 2025-Q1 | 10 | 99.07 | 0.52 | 99.28 | +0.21 | |
| TFS-{CAT}-1476 | 5-Amino-1MQ | 10 Jun 2024 | 2024-Q4 | 4 | 99.82 | 0.39 | 99.90 | +0.08 | |
| TFS-{CAT}-1523 | NAD+ | 11 Mar 2024 | 2024-Q2 | 1 | 99.72 | n<2 | 99.81 | +0.09 | |
| TFS-{CAT}-9824 | MOTS-c | 05 Mar 2024 | 2024-Q3 | 6 | 99.93 | 0.09 | 99.90 | -0.03 | |
| TFS-{CAT}-9522 | Retatrutide | 28 Aug 2023 | 2024-Q1 | 6 | 98.72 | 0.65 | 98.27 | -0.45 |